Search

The reversibility and stability of zinc (Zn) metal anode are closely related to inner Helmholtz plane (IHP) chemistry. The H2O‐rich IHP raises severe parasitic reactions and irregular Zn deposition, impeding the practical utility of Zn anode in aqueous Zn‐ion batteries (AZIBs). In this study, tetrahydropyran (THP), a five‐carbon heterocyclic ether with permanent dipole moment and hydrophobic characteristic, is introduced as a self‐adsorptive additive to reshape the IHP. It squeezes out partial H2O molecules and forms a H2O‐lean IHP, benefitting for alleviating active H2O decomposition and improving the stability of Zn anode. Moreover, the adsorbed THP induces the preferential nucleation of Zn (002) plane, facilitating dendrite‐free growth and improving the reversibility of Zn anode. Consequently, the Zn||Zn symmetric cell enables to cycle over 3600 h at 5 mA cm−2@ 1 mAh cm−2. The Zn||Cu half‐cell can stably cycle over 400 cycles with 99.9% coulombic efficiency even under harsh test conditions (10 mA cm−2@5 mAh cm−2) with 30 µm Zn foil. The Zn||NH4V4O10 full cell maintains 92.6% capacity retention after 800 cycles at 1 A g−1 and the Zn||I2 full cell enables to perform steadily over 10000 cycles with a capacity decay rate of merely 0.003% per cycle at 5 C. [ABSTRACT FROM AUTHOR]

A new series of 3-substituted 4-(4-methyloxy phenyl)-1 H-pyrrole derivatives were synthesized and biologically evaluated for potential anticancer activity. Fifteen targeted compounds showed high selectivity toward normal cells and cancer cells: that is, all targeted compounds had no obvious cytotoxicity toward normal human cells ( HUVEC and NIH/ 3T3), but some compounds exhibited broad-spectrum proliferation inhibitory activity against the screened cancer cell lines. Among these pyrrole derivatives, compounds 3b and 3o showed potent anticancer activity against the MG-63 cell line, with IC50 values of 14.9 and 12.7 μM, respectively. Other pyrrole derivatives also showed promising proliferation inhibitory activity, including compound 3d against A375 ( IC50 = 18.6 μM), compound 3f and 3j against MGC80-3 ( IC50 = 19.9 μM), and compound 3o against MGC80-3 ( IC50 = 11.9 μM). Because the developed pyrrole derivatives showed strong anticancer activity and high selectivity, this new series of pyrrole derivatives could be considered as promising lead compounds for further development of potent and safe anticancer agents. [ABSTRACT FROM AUTHOR]